Published in Clin Exp Immunol on October 01, 1970
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13
Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines. J Clin Invest (1972) 3.64
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49
Multiple DNA fragment polymorphisms associated with immunoglobulin mu chain switch-like regions in man. Proc Natl Acad Sci U S A (1983) 3.07
Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci U S A (1980) 2.35
Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci U S A (1985) 2.26
Primary bioassay of human myeloma stem cells. J Clin Invest (1977) 2.25
Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci U S A (1996) 2.15
Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood (2005) 1.96
The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non-allelic genes. EMBO J (1982) 1.75
Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production. Proc Natl Acad Sci U S A (1983) 1.70
Structure and expression of the human immunoglobulin lambda genes. J Exp Med (1990) 1.56
Cloning and sequence determination of the gene for the human immunoglobulin epsilon chain expressed in a myeloma cell line. Proc Natl Acad Sci U S A (1982) 1.48
High levels of tRNA abundance and alteration of tRNA charging by bortezomib in multiple myeloma. Biochem Biophys Res Commun (2009) 1.23
Rapid method for detecting monoclonality in B cell lymphoma in lymph node aspirates using the polymerase chain reaction. J Clin Pathol (1992) 1.21
Monoclonal antibodies with specificity for hairy cell leukemia cells. J Clin Invest (1982) 1.15
Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. Am J Pathol (2003) 1.08
On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc Natl Acad Sci U S A (1992) 1.05
In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proc Natl Acad Sci U S A (1993) 1.05
T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors. Proc Natl Acad Sci U S A (1995) 1.04
Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors. Immunology (1989) 1.03
Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol Pharmacol (2008) 1.02
Interferon alpha induces nucleus-independent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin. Mol Biol Cell (2007) 1.02
Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3. Leuk Lymphoma (2008) 1.01
Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. J Clin Invest (1991) 0.95
Surface receptors on human haematopoietic cell lines. Clin Exp Immunol (1976) 0.95
Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation. Mol Cell Biol (1987) 0.94
Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains. J Clin Invest (1994) 0.94
The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3' hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination. J Biol Chem (2004) 0.93
Small compound 6-O-angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma. PLoS One (2011) 0.91
Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells. Clin Exp Immunol (2006) 0.89
Characterization of multiple myeloma vesicles by label-free relative quantitation. Proteomics (2013) 0.89
Stable "zeta" peptides that act as potent antagonists of the high-affinity IgE receptor. Proc Natl Acad Sci U S A (2002) 0.87
The immunoglobulin-like modules Cepsilon3 and alpha2 are the minimal units necessary for human IgE-FcepsilonRI interaction. J Clin Invest (1999) 0.86
Two new IgA1-kappa plasma cell leukaemia cell lines (JJN-1 & JJN-2) which proliferate in response to B cell stimulatory factor 2. Clin Exp Immunol (1989) 0.84
Expression of a biologically active fragment of human IgE epsilon chain in Escherichia coli. Proc Natl Acad Sci U S A (1984) 0.84
Morphologic and functional characteristics of long-term cultures of murine myeloma cells. Am J Pathol (1972) 0.84
Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide. Int J Oncol (2012) 0.84
Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines. PLoS One (2011) 0.83
Cellular localizations and processing of the two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen. The protein kinase Ki-1/57 occurs in the nucleus. Am J Pathol (1992) 0.83
Human myeloma cells and their strong stimulating capacity in 'one-way' mixed lymphocyte reaction: a comparative study with leukaemic B lymphoid cells. Immunology (1979) 0.83
Synthesis and secretion of IgE by an established human myeloma cell line. Clin Exp Immunol (1971) 0.82
Antibody producing human-human hybridomas. II. Derivation and characterization of an antibody specific for human leukemia cells. J Exp Med (1984) 0.81
IgE is expressed on, but not produced by, fetal cells in the human placenta irrespective of maternal atopy. Clin Exp Immunol (2002) 0.81
In vitro aggregation behavior of a non-amyloidogenic λ light chain dimer deriving from U266 multiple myeloma cells. PLoS One (2012) 0.80
HLXB9 gene expression, and nuclear location during in vitro neuronal differentiation in the SK-N-BE neuroblastoma cell line. PLoS One (2014) 0.79
Effect of prostaglandins and cyclic nucleotides on growth and immunoglobulin secretion of two IgE myeloma cell lines. Br J Cancer (1981) 0.79
Proteomic changes during B cell maturation: 2D-DIGE approach. PLoS One (2013) 0.78
Interferon-alpha down-regulates the interleukin-6 receptor in a human multiple myeloma cell line, U266. Biochem J (1995) 0.78
Density gradient separation of lymphoid cells adhering to protein-A-containing staphylococci. Proc Natl Acad Sci U S A (1974) 0.78
A B-cell hybridoma product inhibiting antibody secretion via 5'-nucleotidase. Clin Exp Immunol (1985) 0.78
Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders. Dialogues Clin Neurosci (2016) 0.77
Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma. Redox Biol (2016) 0.77
TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition. Cell Cycle (2016) 0.77
The effect of interferon-alpha on the ecto 5'-nucleotidase of human lymphoblastoid B-cell lines depends on the class of immunoglobulin secreted. Immunology (1991) 0.77
Decursin and Doxorubicin Are in Synergy for the Induction of Apoptosis via STAT3 and/or mTOR Pathways in Human Multiple Myeloma Cells. Evid Based Complement Alternat Med (2013) 0.77
Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients. Biomark Res (2014) 0.76
Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas. Pathogens (2012) 0.76
Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models. Cancer Immunol Immunother (2016) 0.75
Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL. Anticancer Drugs (2016) 0.75
Comparison of IgE expression at the mRNA and protein levels in vitro. Immunology (1991) 0.75
The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease. PLoS One (2016) 0.75
Phenotypic and functional characterization of a bortezomib-resistant multiple myeloma cell line by flow and mass cytometry. Leuk Lymphoma (2016) 0.75
EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency. PLoS Biol (2017) 0.75
A new class of immunoglobulin in human serum. Immunology (1968) 4.19
Immunological studies of an atypical (myeloma) immunoglobulin. Immunology (1967) 3.52
Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med (1967) 2.47
Quantitative immunoglobulin determination. Comparison of two methods. Estimation of normal levels and levels in persons lacking IgA and IgD. Acta Pathol Microbiol Scand (1968) 1.51
Morphology of cultured hematopoietic cells. Cancer (1968) 1.28
Isolation and characterization of free gamma chain of immunoglobulin produced by an established cell line of human myeloma cell origin. I. Gamma chain in culture medium. J Immunol (1969) 1.23
Development of immunocytes and immunoglobulin production in long-term cultures from normal and malignant human lymph nodes. Int J Cancer (1968) 1.14
Chromosomes and cloning efficiencies of hematopoietic cell lines derived from patients with leukemia, melanoma, myeloma, and Burkitt lymphoma. J Natl Cancer Inst (1969) 1.12
Cell line derived from patient with myeloma. N Y State J Med (1968) 1.10
Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A (1991) 6.42
Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet (1967) 6.12
Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature (1981) 5.66
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13
Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand (1968) 4.82
A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol (1999) 4.43
Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer (1976) 4.35
The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol (2007) 4.22
A new class of immunoglobulin in human serum. Immunology (1968) 4.19
Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet (1967) 3.63
Immunological studies of an atypical (myeloma) immunoglobulin. Immunology (1967) 3.52
A massive binary black-hole system in OJ 287 and a test of general relativity. Nature (2008) 3.50
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49
Insect immunity. Attacins, a family of antibacterial proteins from Hyalophora cecropia. EMBO J (1983) 3.27
Fasting capillary glucose as a screening test for gestational diabetes mellitus. BJOG (2006) 3.23
Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae. Eur J Biochem (1982) 3.17
A primordial tRNA modification required for the evolution of life? EMBO J (2001) 3.01
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer (1971) 2.96
IgE concentrations in children with atopic diseases. A clinical study. Int Arch Allergy Appl Immunol (1969) 2.84
K562--a human erythroleukemic cell line. Int J Cancer (1979) 2.84
Immunoglobulin levels in Ethiopian preschool children with special reference to high concentrations of immunoglobulin E (IgND). Lancet (1968) 2.72
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69
Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. Adv Cancer Res (1982) 2.68
Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol (1981) 2.65
International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst (2000) 2.41
Subfragments from the Fc fragment of human immunoglobulin G. Isolation and physicochemical charaterization. Biochem J (1968) 2.26
Antibodies to Toxocara in the sera of visceral larva migrans patients: the significance of raised levels of IgE. Clin Exp Immunol (1969) 2.26
The relationship between in vitro transformation and tumor formation in vivo. Biochim Biophys Acta (1976) 2.24
Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand A (1973) 2.23
Classification and biological nature of established human hematopoietic cell lines. Int J Cancer (1975) 2.16
Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. Virology (1987) 2.11
Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature (1980) 2.08
High-frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood. Int J Cancer (1971) 2.06
A research standard for human serum immunoglobulin E. Bull World Health Organ (1970) 2.05
Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer (1967) 1.99
The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods (1987) 1.98
Low cardiac output abolishes cardiovascular responses to infra-renal aortic cross-clamping in the pig. Acta Anaesthesiol Scand (1997) 1.97
MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res (1999) 1.90
Role of IgE receptors in effector function of human eosinophils. J Immunol (1984) 1.87
Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer. J Natl Cancer Inst (1993) 1.87
Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer (1977) 1.84
Histamine release from human leukocytes by anti-gamma E antibodies. J Immunol (1969) 1.84
Serum IgE levels in healthy children quantified by a sandwich technique (PRIST). Clin Allergy (1976) 1.83
The radioallergosorbent test in the in vitro diagnosis of multiple reaginic allergy. A comparison of diagnostic approaches. J Allergy Clin Immunol (1971) 1.83
Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy. Br Med J (Clin Res Ed) (1981) 1.83
Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst (1989) 1.82
Specific inhibition of the Prausnitz-Küstner reaction by an atypical human myeloma protein. Lancet (1967) 1.76
Detection of IgE(IgND) specific antibody (probably reagin) to castor-bean allergen by the red-cell-linked antigen-antiglobulin reaction. Lancet (1968) 1.75
Nasal continuous positive airway pressure: experiences with a new technical approach. Acta Paediatr (1993) 1.74
Transfer RNA modification: influence on translational frameshifting and metabolism. FEBS Lett (1999) 1.73
Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol (1994) 1.73
Establishment and characteristics of two unique cell lines from patients with lymphosarcoma. Int J Cancer (1974) 1.73
Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol (2001) 1.72
Soy versus cow's milk in infants with a biparental history of atopic disease: development of atopic disease and immunoglobulins from birth to 4 years of age. Clin Allergy (1979) 1.70
Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene (1994) 1.69
Structure and function of human immunoglobulin E. Adv Immunol (1971) 1.67
Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66
Immunoglobulin levels in healthy children. Acta Paediatr Scand (1967) 1.66
Very-high-energy gamma rays from a distant quasar: how transparent is the universe? Science (2008) 1.65
Immunoglobulin E in dermatoses. Levels in atopic dermatitis and urticaria. Arch Dermatol (1969) 1.63
Fc receptors for IgE on human and rat eosinophils. J Immunol (1981) 1.63
In vitro diagnosis of atopic allergy. I. A comparison between provocation tests and the radioallergosorbent test. Int Arch Allergy Appl Immunol (1971) 1.60
The solution conformation of the antibacterial peptide cecropin A: a nuclear magnetic resonance and dynamical simulated annealing study. Biochemistry (1988) 1.58
Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes. Transplant Rev (1974) 1.57
Immunological mystery of coeliac disease. Lancet (1969) 1.56
Changes in immunoglobulin levels in severely burned patients. Lancet (1969) 1.53
Quantitative immunoglobulin determination. Comparison of two methods. Estimation of normal levels and levels in persons lacking IgA and IgD. Acta Pathol Microbiol Scand (1968) 1.51
The clinical significance of IgE. Prog Clin Immunol (1972) 1.51
International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer (1997) 1.50
The division cycle and RNA-synthesis in diploid human cells at different passage levels in vitro. Exp Cell Res (1966) 1.48
Allergy diagnosis with the radioallergosorbent test: A comparison with the results of skin and provocation tests in an unselected group of children with asthma and hay fever. J Allergy Clin Immunol (1974) 1.47
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia (2006) 1.47
Storage mite allergy is common in a farming population. Clin Allergy (1985) 1.47
The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. JAMA (1990) 1.45
Effects of exogenous stress protein 70 on the functional properties of human promonocytes through binding to cell surface and internalization. Cell Stress Chaperones (1998) 1.45
Properties of human malignant glioma cells in vitro. Med Biol (1978) 1.44
Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med (1981) 1.43
Natural killer cells kill tumour cells at a given stage of differentiation. Nature (1981) 1.43
Further studies on the effect of adenine in blood preservation. Transfusion (1967) 1.42
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. Haematol Blood Transfus (1981) 1.42
Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells. Leukemia (1989) 1.42
Immunoglobulins in tracheo-bronchial secretion with special reference to IgE. Clin Exp Immunol (1974) 1.42
Allergenic characterization of Acarus siro and Tyrophagus putrescentiae and their crossreactivity with Lepidoglyphus destructor and Dermatophagoides pteronyssinus. Clin Exp Allergy (1994) 1.41
Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene (1996) 1.40
Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303. Science (2006) 1.40
Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Tumour Biol (1998) 1.40
A novel mutation in the beta-protein coding region of the amyloid beta-protein precursor (APP) gene. Hum Genet (1992) 1.39